Get Involved
Get Involved
0+
0+
MaVen’s Network Spans Across Collaborating Institutions.
We are grateful for the support of our network and our home institution – the University Health Network (UHN) McEwen Stem Cell Institute.
0+
0+
MaVen’s Network Spans Across Collaborating Institutions.
We are grateful for the support of our network and our home institution – the University Health Network (UHN) McEwen Stem Cell Institute.
0+
0+
Principal Investigators
Supported by the Government of Canada’s New Frontiers in Research Fund, MaVen brings together 22 Principal Investigators from 10 different institutions. A highly interdisciplinary approach is our key to making a big impact in high-risk, high-reward areas of research.
0+
0+
Principal Investigators
Supported by the Government of Canada’s New Frontiers in Research Fund, MaVen brings together 22 Principal Investigators from 10 different institutions. A highly interdisciplinary approach is our key to making a big impact in high-risk, high-reward areas of research.
A journey through the science shaping tomorrow’s medicine.
Our Three Major Deliverables
Our Three Major Deliverables
Can we establish scalable, economic methods for manufacturing stem-cell derived cardiac tissues for non-invasive delivery to injured myocardium?
Can we exploit recent advances in synthetic biology and gene-editing to engineer stem-cell derived cardiomyocytes that will survive better post-transplantation?
Can we ultimately advance from delivery of cardiac cells to replacement of the failing organ itself?
Explore
Can we establish scalable, economic methods for manufacturing stem-cell derived cardiac tissues for non-invasive delivery to injured myocardium?
Can we exploit recent advances in synthetic biology and gene-editing to engineer stem-cell derived cardiomyocytes that will survive better post-transplantation?
Can we ultimately advance from delivery of cardiac cells to replacement of the failing organ itself?
Explore
Can we establish scalable, economic methods for manufacturing stem-cell derived cardiac tissues for non-invasive delivery to injured myocardium?
Can we exploit recent advances in synthetic biology and gene-editing to engineer stem-cell derived cardiomyocytes that will survive better post-transplantation?
Can we ultimately advance from delivery of cardiac cells to replacement of the failing organ itself?
Explore
Can we establish scalable, economic methods for manufacturing stem-cell derived cardiac tissues for non-invasive delivery to injured myocardium?
Can we exploit recent advances in synthetic biology and gene-editing to engineer stem-cell derived cardiomyocytes that will survive better post-transplantation?
Can we ultimately advance from delivery of cardiac cells to replacement of the failing organ itself?
Explore
Can we establish scalable, economic methods for manufacturing stem-cell derived cardiac tissues for non-invasive delivery to injured myocardium?
Can we exploit recent advances in synthetic biology and gene-editing to engineer stem-cell derived cardiomyocytes that will survive better post-transplantation?
Can we ultimately advance from delivery of cardiac cells to replacement of the failing organ itself?
Explore
Can we establish scalable, economic methods for manufacturing stem-cell derived cardiac tissues for non-invasive delivery to injured myocardium?
Can we exploit recent advances in synthetic biology and gene-editing to engineer stem-cell derived cardiomyocytes that will survive better post-transplantation?
Can we ultimately advance from delivery of cardiac cells to replacement of the failing organ itself?
Explore
Can we establish scalable, economic methods for manufacturing stem-cell derived cardiac tissues for non-invasive delivery to injured myocardium?
Can we exploit recent advances in synthetic biology and gene-editing to engineer stem-cell derived cardiomyocytes that will survive better post-transplantation?
Can we ultimately advance from delivery of cardiac cells to replacement of the failing organ itself?
Explore
Can we establish scalable, economic methods for manufacturing stem-cell derived cardiac tissues for non-invasive delivery to injured myocardium?
Can we exploit recent advances in synthetic biology and gene-editing to engineer stem-cell derived cardiomyocytes that will survive better post-transplantation?
Can we ultimately advance from delivery of cardiac cells to replacement of the failing organ itself?
Explore
Can we establish scalable, economic methods for manufacturing stem-cell derived cardiac tissues for non-invasive delivery to injured myocardium?
Can we exploit recent advances in synthetic biology and gene-editing to engineer stem-cell derived cardiomyocytes that will survive better post-transplantation?
Can we ultimately advance from delivery of cardiac cells to replacement of the failing organ itself?
Explore
At the core of these cutting-edge stem cell-based cardiac therapies is the collaborative effort of an interdisciplinary team of researchers from around the globe.
Meet the Team
Our works guide the next wave of stem-cell driven cardiac therapies. With each discovery, we bring regenerative solutions closer to clinical reality.
Publications
Sep 10, 2026
Apr 17, 2026
Nov 23, 2025
Jun 30, 2025
Jan 18, 2025
Jul 3, 2023
Get Involved
Get Involved
Get Involved